Cognition Therapeutics
CGTX
78 hedge funds and large institutions have $28.9M invested in Cognition Therapeutics in 2025 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 8 closing their positions.
113% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 8
13% more funds holding
Funds holding: 69 → 78 (+9)
1% more capital invested
Capital invested by funds: $28.7M → $28.9M (+$204K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 16
4.66% less ownership
Funds ownership: 28.93% → 24.27% (-4.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.03M |
| 2 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
+$756K |
| 3 |
Renaissance Technologies
New York
|
+$416K |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
+$325K |
| 5 |
DC
Davenport & Co
Richmond,
Virginia
|
+$296K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.62M |
| 2 |
Millennium Management
New York
|
-$805K |
| 3 |
Jane Street
New York
|
-$506K |
| 4 |
QC
Quadrature Capital
London,
United Kingdom
|
-$379K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$299K |
CGTX Hedge Fund Activity: Q4 2025 in Review
78 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q4 2025, worth a combined $28.9M — up 0.71% from $28.7M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CGTX positions and 8 closed out — a net gain of 9 holders — while 16 added to existing stakes and 16 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.03M. The largest seller was Tang Capital Management, exiting entirely with an estimated $1.62M sold.
- 78 institutional investors held Cognition Therapeutics (CGTX) as of Q4 2025, up from 69 in Q3 2025.
- Funds reported $28.9M of Cognition Therapeutics stock for Q4 2025, up 0.71% quarter-over-quarter.
- 17 funds opened new Cognition Therapeutics positions in Q4 2025 and 8 closed out, a net change of +9 holders.
- The largest Cognition Therapeutics buyer in Q4 2025 was Vanguard Group, an estimated $1.03M added.
- The largest Cognition Therapeutics seller in Q4 2025 was Tang Capital Management, an estimated $1.62M sold.
Based on aggregated 13F filings for Q4 2025.